Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PAOX | Q6QHF9 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.42 |
| ▸ | APP | P05067 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 2/20 | 0.41 |
| ▸ | CA2 | P00918 | 2/20 | 0.41 |
| ▸ | RELA | Q04206 | 4/20 | 0.40 |
| ▸ | S1PR2 | O95136 | 5/20 | 0.39 |
| ▸ | S1PR4 | O95977 | 5/20 | 0.39 |
| ▸ | S1PR1 | P21453 | 5/20 | 0.39 |
| ▸ | S1PR3 | Q99500 | 5/20 | 0.39 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.39 |
| ▸ | PPARA | Q07869 | 2/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | ADH1B | P00325 | 1/20 | 0.37 |
| ▸ | ADH1A | P07327 | 1/20 | 0.37 |
| ▸ | ADH7 | P40394 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15305904 | 0.95 | PAOX (0.52) | PAOXALDH1A1TSHREPHX2APP | |
| Tetramethylammonium Ion SCHEMBL10009677 | 0.94 | PAOX (0.47) | PAOXALDH1A1TSHREPHX2APP | |
| SCHEMBL22800826 | 0.93 | PAOX (0.50) | PAOXALDH1A1TSHREPHX2APP | |
| SCHEMBL22800835 | 0.93 | PAOX (0.50) | PAOXALDH1A1TSHREPHX2APP | |
| SCHEMBL15927268 | 0.93 | PAOX (0.45) | PAOXALDH1A1TSHREPHX2APP | |
| SCHEMBL917681 | 0.91 | ALDH1A1 (0.59) | PAOXALDH1A1TSHREPHX2CA1 | |
| SCHEMBL354553 | 0.91 | TSHR (0.52) | PAOXALDH1A1TSHREPHX2APP | |
| SCHEMBL917570 | 0.89 | ALDH1A1 (0.56) | ALDH1A1TSHREPHX2CA1CA2 | |
| SCHEMBL918549 | 0.89 | ALDH1A1 (0.56) | ALDH1A1TSHREPHX2CA1CA2 | |
| SCHEMBL918208 | 0.89 | ALDH1A1 (0.56) | ALDH1A1TSHREPHX2CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 103 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2658810-A2 | METHOD FOR IMPROVING TOTAL ENERGY DEMAND IN A POST-COMBUSTION CARBON CAPTURE PROCESS WITH IONIC ABSORBENT | Chevron U.S.A. Inc. (US) | 2013-11-06 | — | — | EP | claimed |
| WO-2012092204-A2 | METHOD FOR IMPROVING TOTAL ENERGY DEMAND IN A POST-COMBUSTION CARBON CAPTURE PROCESS WITH IONIC ABSORBENT | CHEVRON U.S.A. INC. (US) | 2012-07-05 | — | — | WO | claimed |
| EP-3760657-B1 | HYDROPHILIZING AGENT FOR PRODUCTION OF SELF-EMULSIFYING POLYISOCYANATE COMPOSITION, SELF-EMULSIFYING POLYISOCYANATE COMPOSITION, COATING MATERIAL COMPOSITION, AND COATING FILM | TOSOH CORP (JP) | 2025-04-02 | — | — | EP | disclosed |
| CN-119080234-A | Preparation method of enhanced denitrification and denitrification slow-release carbon source | 神美科技有限公司 | 2024-12-06 | — | — | CN | disclosed |
| US-12134677-B2 | Hydrophilizing agent for production of self-emulsifying polyisocyanate composition, self-emulsifying polyisocyanate composition, coating material composition, and coating film | TOSOH CORPORATION (JP) | 2024-11-05 | — | — | US | disclosed |
| US-12024533-B2 | Antimicrobial organosilanes | TOPIKOS SCIENTIFIC, INC. (US) | 2024-07-02 | — | — | US | disclosed |
| EP-4107198-B1 | POLYISOCYANATE PREPARATIONS | COVESTRO DEUTSCHLAND AG (DE) | 2024-03-13 | — | — | EP | disclosed |
| CN-117295486-A | Cosmetic for skin penetration of hyaluronate | 株式会社资生堂 | 2023-12-26 | — | — | CN | disclosed |
| EP-3560975-B2 | IONICALLY HYDROPHILIZED POLYISOCYANATES AND ANTIOXIDANTS | COVESTRO INTELLECTUAL PROPERTY GMBH & CO KG (DE) | 2023-12-06 | — | — | EP | disclosed |
| EP-3724251-B2 | IONICALLY HYDROPHILIZED POLYISOCYANATES, WATER CONTENT | COVESTRO INTELLECTUAL PROPERTY GMBH & CO KG (DE) | 2023-11-22 | — | — | EP | disclosed |
| US-20230295195-A1 | ANTIMICROBIAL ORGANOSILANES | Tipikos Pharmaceuticals, Inc. (US) | 2023-09-21 | — | — | US | disclosed |
| US-8044100-B2 | Methods and compositions for treating amyloid-related diseases | BELLUS HEALTH INC. (CA) | 2011-10-25 | — | — | US | disclosed |
| WO-2011051422-A2 | TREATING WATER INSOLUBLE NANOPARTICLES WITH HYDROPHILIC ALPHA-HYDROXYPHOSPHONIC ACID CONJUGATES, THE SO MODIFIED NANOPARTICLES AND THEIR USE AS CONTRAST AGENTS | GENERAL ELECTRIC COMPANY (US) | 2011-05-05 | — | — | WO | disclosed |
| US-20110104072-A1 | TREATING WATER INSOLUBLE NANOPARTICLES WITH HYDROPHILIC ALPHA-HYDROXYPHOSPHONIC ACID CONJUGATES, THE SO MODIFIED NANOPARTICLES AND THEIR USE AS CONTRAST AGENTS | GENERAL ELECTRIC COMPANY (US) | 2011-05-05 | — | — | US | disclosed |
| EP-1836161-A2 | METHODS AND COMPOSITIONS FOR TREATING AMYLOID-RELATED DISEASES | Neurochem (International) Limited (CH) | 2007-09-26 | — | — | EP | disclosed |
| US-20060223855-A1 | reduces or inhibits amyloid fibril formation, organ specific dysfunction (e.g., neurodegeneration), or cellular toxicity | NEUROCHEM (INTERNATIONAL) LIMITED (CH) | 2006-10-05 | — | — | US | disclosed |
| WO-2006085149-A2 | METHODS AND COMPOSITIONS FOR TREATING AMYLOID-RELATED DISEASES | NEUROCHEM (INTERNATIONAL) LIMITED (CH) | 2006-08-17 | — | — | WO | disclosed |
| EP-0494686-B1 | Process for effecting high efficiency separations by capillary electrophoresis | MILLIPORE CORP (US) | 1995-03-08 | — | — | EP | disclosed |
| US-5192405-A | Process for effecting high efficiency separations by capillary electrophoresis | MILLIPORE CORPORATION (US) | 1993-03-09 | — | — | US | disclosed |
| EP-0494686-A1 | Process for effecting high efficiency separations by capillary electrophoresis | MILLIPORE CORPORATION (US) | 1992-07-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060223855-A1 | reduces or inhibits amyloid fibril formation, organ specific dysfunction (e.g., neurodegeneration), or cellular toxicity | APP, IAPP, BACE1 | PAOX 2260/4885ALDH1A1 2230/4885TSHR 4277/4885 |
| US-20110104072-A1 | TREATING WATER INSOLUBLE NANOPARTICLES WITH HYDROPHILIC ALPHA-HYDROXYPHOSPHONIC ACID CONJUGATES, THE SO MODIFIED NANOPARTICLES AND THEIR USE AS CONTRAST AGENTS | HAMP, SLC46A1, CD44 | PAOX 821/4885ALDH1A1 1677/4885TSHR 358/4885 |
| US-12024533-B2 | Antimicrobial organosilanes | ARG1, ACMSD, AAAS | PAOX 2315/4885ALDH1A1 2951/4885TSHR 4128/4885 |
| US-20230295195-A1 | ANTIMICROBIAL ORGANOSILANES | ARG1, ACMSD, AAAS | PAOX 2315/4885ALDH1A1 2951/4885TSHR 4128/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.